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Evaluation of adjuvant psychological therapy for clinically referred
cancer patients
S. Greer, S. Moorey & J. Baruch
Cancer Research Campaign Psychological Medicine Group, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK.
Summary Adjuvant psychological therapy (APT) is a newly developed cognitive behavioural treatment which
has been designed specifically to improve the quality of life of cancer patients by alleviating emotional distress
and inducing a fighting spirit. We report a phase I/II study which evaluates APT in routine clinical practice. A
consecutive series of 44 outpatients with various cancers referred for psychiatric consultation and receiving
APT at the Royal Marsden Hospital was studied. Standardised self-report questionnaires were used to
measure anxiety, depression and four principal categories of mental adjustment to cancer, namely, fighting
spirit, helplessness, anxious preoccupation and fatalism. Statistical comparisons between pre-therapy scores
and scores after an average of five APT sessions revealed significant improvement in anxiety, depression,
fighting spirit, anxious preoccupation and helplessness. Fatalism scores showed the same trend, but the
changes were smaller. Patients with advanced disease showed as much improvement as those with local or
locoregional disease. Present results indicate improvement in both psychiatric symptoms and mental adjust-
ment to cancer associated with APT. Whether this association is causal remains to be determined by
randomised controlled trials. Such a trial is in progress.
Psychological and social morbidity among cancer patients
has been well documented in several systematic studies
(Morris et al., 1977; Plumb & Holland, 1977; Maguire et al.,
1978; Derogatis et al., 1983; Hughes, 1987). Such morbidity
may persist for years in long-term survivors even in the
absence of any signs of disease (Fobair et al., 1986). Increas-
ing concern about the quality of life of cancer patients has
led, recently, to the development of psychological treatment
programmes for these patients. Like all treatments in
medicine, such psychotherapeutic procedures should be
scientifically evaluated by means of randomised controlled
trials. The few randomised trials reported so far have pro-
duced inconsistent results, reflecting differences in patient
populations, in types of psychological treatment and in
measures of outcome (Greer, 1989). Certain methodological
problems inherent in psychotherapy trials have been iden-
tified; though complex and difficult, these problems are not
insurmountable (Cawley, 1983; Moorey & Greer, 1989).
The requirements ofwell-designed trials often lead to study
designs which are methodologically rigorous but not directly
applicable to clinical practice. Highly specific homogeneous
patient samples, screened populations and extensive exclusion
criteria may contribute to a marked discrepancy between the
experience of patients entering a randomised trial and that
obtaining in clinical practice. We are at present conducting a
randomised trial of adjuvant psychological therapy (see
below). Patients with primary cancers or first recurrence are
being screened psychologically by means of standardised
questionnaires. Those patients who have high scores indicat-
ing psychological morbidity are invited to take part in our
trial and, if they agree, are randomised to either therapy or a
no therapy control group. Compare this with normal clinical
practice at the same hospital: patients who, at medical con-
sultation, appear unduly anxious, depressed or otherwise
emotionally distressed are referred by their clinicians to the
Psychological Medicine department. Hence, although patients
receive adjuvant psychological therapy (APT) whether in the
trial or clinically referred, the ways in which they come to
therapy differ widely.
In addition to research which evaluates APT in patients
discovered to have psychological disturbance through screen-
ing methods, there is a place for evaluation of its efficacy in
clinically referred patients. Clearly, on ethical grounds it
would be undesirable to allocate such patients to a no-
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treatment control group. As a first step in demonstrating the
effectiveness of APT, there is a place for uncontrolled studies
of psychological therapy for clinically referred cancer
patients. This kind of study should then be followed by
randomised controlled trials in which APT is compared with
no treatment and, possibly, with other forms ofpsychological
therapy. The present study reports an uncontrolled evalua-
tion of APT in routine clinical practice: anxiety, depression
and mental adjustment to cancer among patients referred for
psychiatric consultation are compared before and after APT.
Materials and methods
A consecutive series of out-patients with a confirmed diag-
nosis of cancer referred for psychiatric consultation at The
Royal Marsden Hospital was studied. Patients were entered
in the trial: (i) if they were suffering from a formal psychi-
atric disorder (excluding organic mental disorders, schizo-
phrenia and other psychotic disorders); or (ii) if their
psychological disturbance, though not reaching the level of a
formal psychiatric disorder, was sufficiently severe to have
resulted in more than transient distress. All patients referred
during a specified period who fulfilled these criteria were
entered in the study.
Adjuvantpsychological therapy (APT)
A full description of APT has been provided by Moorey and
Greer (1989). APT is a brief structured treatment programme
in which the principles ofcognitive therapy are applied to the
specific problems of cancer patients. Cognitive therapy aims
to alleviate emotional disorders by identifying and correcting
maladaptive thinking (Beck, 1976). Applied to cancer-related
psychological disorders, it is hypothesised that these dis-
orders depend not only on the physical effects of the disease
process but also on two crucial factors: (1) the personal
meaning of the disease, i.e. how the patient perceives cancer
and its implications; and (2) the patient's coping ability, i.e.
what the patient thinks and does to reduce the threat posed
by cancer. These factors are influenced, in turn, by the degree
of emotional support given by family and friends as well as
by medical and nursing staff.
APT is focused on these factors. Therapy is directed
primarily at current problems and teaches patients new cop-
ing skills. APT is conducted with individual patients and,
where possible, the spouse. Approximately six sessions, each
lasting an hour, are held; occasionally more sessions are
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required. The therapeutic relationship is a collaborative one
in which the therapist and patient set an agreed agenda,
defining the specific problems to be addressed. These prob-
lems are then tackled using various cognitive and behavioural
techniques including the following: (a) Patients are taught (i)
to identify and record negative automatic thoughts, and (ii)
to challenge these thoughts by reality testing; in this way, the
negative thoughts can be replaced by more realistic, adaptive
coping responses. (b) Patients are encouraged to rehearse, in
imagination and role play, impending stressful events and to
practise ways of coping with such events. (c) Patients are
encouraged to plan and carry out various activities which
give both a sense of mastery or control over some aspects of
their lives and a sense of pleasure. (d) Relaxation training is
used if anxiety is severe. (e) Patients are encouraged to
express feelings openly. Frank mutual communication of feel-
ings between the patient and spouse is encouraged in ses-
sions. (f) The personal strengths of the patient are identified
and fostered as a means of raising self-esteem, overcoming
feelings of helplessness and inducing a fighting spirit. (g)
When the patient's predominant reaction to cancer is avoid-
ance (denial) this is not challenged. The disease is not dis-
cussed; instead, therapy is focused on any symptoms present
and on developing coping skills which will enable the patient
to resume normal life as quickly as possible.
Measures ofoutcome
Anxiety and Depression were measured using the Hospital
Anxiety and Depression (HAD) scale. This self-rating scale is
designed to detect states of anxiety and depression in patients
with physical illnesses (Zigmond & Snaith, 1983). It has the
advantage that somatic items are excluded as far as possible,
so that depression scores are not affected by symptoms such
as weight loss and anorexia which are frequently associated
with cancer itself.
Adjustment to cancer refers to the patient's perception of
the implications of cancer and his or her coping strategies,
i.e. what the patient thinks and does to reduce the threat
posed by cancer. Previous work by our research group has
shown that adjustment to cancer can be grouped in the
following major categories: fighting spirit, helplessness, anx-
ious preoccupation, fatalism and avoidance (denial). We have
developed a self-rating questionnaire, the Mental Adjustment
to Cancer (MAC) scale, which measures the first four of
these psychological responses (Greer & Watson, 1987; Wat-
son et al., 1988).
The HAD and MAC self-rating scales were completed by
patients before therapy and 8 weeks later. Relevant demo-
graphic and clinical data including diagnosis, stage of
disease, physical performance status (WHO, 1979) and treat-
ments were recorded. A broad staging classification which
subsumes all types of cancer seen in this study was used:
stage I, local disease only; stage II, locoregional disease, i.e.
lymph node involvement (lymphoma grades I and II are
included here); stage III, distant metastases (lymphoma
grades III and IV and systemic malignant diseases such as
leukaemia and myeloma are included here).
Results
Forty-four consecutive patients who received at least two
sessions of APT were assessed before APT and 8 weeks later.
The demographic and clinical characteristics of the patients
are shown in Table I.
Psychological therapy (APT)
During the 8 weeks' interval between psychological assess-
ments, patients received two to eight (mean 4.55) sessions of
APT. At the final 8 weeks assessment, 21 patients (48%)
were judged to have completed therapy and discharged; the
remaining patients received several more APT sessions in the
ensuing weeks. All results here refer to the psychological
Table I Patient characteristics
Cancer site
Age (years)
Mean 47.9
Range 17-77
Sex
Male 14 (32%)
Female 30 (68%)
Marital state
Single
Married/cohabiting
Separate/divorced
Widowed
Performance status
0 22
1 15
2 7
3 0
4 0
8 (18%)
29 (66%)
6 (14%)
1 (2%)
(50%)
(34%)
(16%)
Breast
Non-Hodgkin's
lymphoma
Head and neck
G-I tract
Gynaecological
Lung
Melanoma
Myeloma
Prostate/bladder
Other
Stage ofdisease
Local only
Loco-regional
Metastatic
Primary/recurrent disease
Primary 25
Recurrent 19
17 (39%)
7 (16%)
3 (7%)
2 (5%)
2 (5%)
2 (5%)
2 (5%)
2 (5%)
2 (5%)
4 (9%)
12 (27%)
16 (36%)
16 (36%)
(57%)
(43%)
Total no. ofpatients = 44.
status of patients 8 weeks after commencing APT, irrespec-
tive of whether APT had been completed. In addition to
APT, five patients received anti-depressant drugs.
Psychological outcome
Statistical comparisons between the pre-therapy and final (8
weeks) mean scores on the HAD and MAC scales were
carried out, using two-tailed paired t tests. Significant
differences were found, i.e. reductions in anxiety, depression,
helplessness, anxious preoccupation and fatalism and a signi-
ficant increase in fighting spirit (Tables II and III).
In order to examine the effect on psychological outcome of
APT alone, comparisons between initial and final mean
scores were repeated excluding the five patients who had
received anti-depressant medication. The same results as des-
cribed for the whole sample were obtained.
Clinical significance ofchanges in HAD scores
HAD scores range from 0 to 21 for anxiety and for depres-
sion. Scores from 0 to 7 indicate normal levels, 8 to 10 are
regarded as borderline and 11 to 21 indicate severe anxiety or
depression, i.e. psychiatric disorder (Zigmond & Snaith,
1983). The distributions of patients in each category before
therapy and at final assessment are shown in Table IV.
For the purposes of statistical analysis, patients with HAD
scores in the normal range (0-7) were compared with
patients scoring in the borderline and severe ranges (8-21)
before therapy and at final assessment. Table V shows statis-
tically significant reductions in the proportions of patients
with high anxiety and depression scores at final assessment.
No patient became worse.
Table II Changes in HAD scores by psychological therapy (APT)
Pre-APT score Final score
mean (s.d.) mean (s.d.) P
Anxiety 11.8 (4.2) 8.0 (3.6) <0.001
Depression 8.4 (5.3) 5.4 (4.3) <0.001
Table III Changes in MAC scores by psychological therapy (APT)
Pre-APTscore Final score
mean (s.d.) mean (s.d.) P
Fighting spirit 46.1 (6.9) 49.8 (5.7) <0.001
Helplessness 12.7 (4.2) 9.6 (2.9) <0.001
Anxious 26.2 (3.5) 24.2 (4.4) = 0.0012
preoccupation
Fatalism 17.5 (3.7) 16.6 (4.2) = 0.04ADJUVANT PSYCHOLOGICAL THERAPY 259
Table IV Degree of anxiety and depression by APT
Anxiety score
Normal Borderline Severe
0-7 8-10 11-21 Total
Pre-APT (n) 7 (16%) 8 (18%) 29 (66%) 44 (100%)
Final assessment (n) 22 (50%) 13 (30%) 9 (20%) 44
Depression
Pre-APT (n) 22 (50%) 9 (20%) 13 (30%) 44
Final assessment (n) 33 (75%) 6 (14%) 5 (11%) 44
Another way of expressing the results is as follows: (a)
Before therapy, 21 patients had high anxiety and depression
scores, 17 patients had high scores on either anxiety or
depression and six patients had normal anxiety and depres-
sion scores. (b) At final assessment, 11 patients had high
anxiety and depression scores, 12 patients had high scores on
either anxiety or depression and 21 patients had normal
anxiety and depression scores.
Predictors ofpsychological outcome
Multiple regression analyses Two step-wise multiple regres-
sion analyses were carried out with nine possible predictors
of outcome: age, sex, primary versus recurrent disease, stage
of disease, performance status, number of APT sessions,
undergoing chemotherapy or radiotherapy currently (i.e. dur-
ing the last month), side-effects of such therapy, pre-APT
anxiety and depression scores. The two dependent variables
were anxiety and depression scores at 8 weeks. The results
may be summarised as follows. (i) Anxiety scores at 8 weeks:
pre-APT anxiety scores predicted 40% of the variance. (ii)
Depression scores at 8 weeks: pre-APT depression scores
predicted 50.9% of the variance; the addition of age in-
creased the predicted variance to 59%. (iii) No other variable
contributed a significant proportion of the variance.
Analyses of co-variance To test further the influence of
patient and disease characteristics on psychological outcome,
a series of analyses of co-variance was performed using
generalised linear modelling. One-way ANCOVAs were per-
formed on assessment at 8 weeks for anxiety and depression
scores, with pre-therapy scores entered as co-variates.
(i) Anxiety scores at 8 weeks: no effects were found for sex
(F = 0.32; d.f. = 1; P = 0.58), performance status (F = 0.58;
d.f. = 1; P = 0.45), breast cancer versus other diagnoses (F =
0.00; d.f. = 1; P = 0.96), presence of symptoms referrable to
chemo/radiotherapy, primary versus recurrent disease (F =
0.40; d.f. = 1; P = 0.53). Stage of disease just failed to reach
significance (F = 2.97; d.f. = 2; P = 0.06).
(ii) Depression scores at 8 weeks: no effects were found for
sex (F = 0.02; d.f. = 1; P = 0.88), performance status (F =
0.54; d.f. = 1; P = 0.47), breast cancer versus other diagnoses
(F = 0.38; d.f. = 1; P = 0.54), presence of symptoms refer-
rable to chemo/radiotherapy (F = 0.49; d.f. = 2; P = 0.62),
primary versus recurrent disease (F= 2.69; d.f. = 1; P=
0.11), or disease stage (F = 0.40; d.f. = 1; P = 0.675).
No significant effects of interaction were found for any of
these analyses.
Table V Significance ofchanges in anxiety and depression
Final Assessment
Borderline/
HAD Normal severe
scores n n Significancea
Anxiety
Pre-APT Normal 7 0
Borderline/ 16 21 <0.001
severe
Depression
Pre-APT Normal 22 0
Borderline/ 11 11 =I0.03
severe
aMcNemar test for significance ofchange.
Discussion
The introduction of psychological therapy as part of the
overall medical management of patients with cancer is a
recent and, in our view, overdue innovation. Its aim is to
measurably improve the quality of life of patients with
cancer. In order to achieve that aim, alleviation of distressing
psychological ill-health is as necessary as, for example, allevi-
ation of pain. We have developed a systematic psychological
therapy programme, APT, which needs to be evaluated. The
present phase I/II study was undertaken to ascertain the
feasibility of conducting APT in a busy cancer hospital, to
determine the effect of APT on anxiety, depression and men-
tal adjustment to cancer and, lastly, to identify any clinical
predictors of psychological outcome.
Is psychological therapy feasible in a cancer hospital or
oncology department? In our experience this will depend on
two practical conditions. First, therapy cannot be conducted
in hospital wards where conversation can be overheard and
interruptions are common. The provision of consulting
rooms in a sine qua non for psychotherapy. Secondly, the
therapists need to adopt a flexible policy regarding appoint-
ments, fitting these in wherever possible with appointments
to other outpatient and treatment clinics. In this way,
patients who are often physically unwell are not burdened
with frequent visits to hospital and, equally important,
psychological therapy is seen by patients as part of medical
treatment.
Flexibility is also required when planning the duration of
therapy. Although we aimed to have weekly sessions, several
patients could not attend each week either on medical
grounds or because they lived a long distance from the
hospital; hence, the number of APT sessions during the 8
week assessment period varied from two to eight, the average
being five sessions. For obvious reasons, prolonged psycho-
therapy is neither feasible nor appropriate for most cancer
patients. APT has been designed as a short-term therapy. It
follows that, if therapy is successful, measurable psycho-
logical benefit should occur within a brief period. In the
present feasibility study, we have taken 8 weeks after com-
mencement of therapy as the assessment point, irrespective of
the number of sessions or whether therapy had been com-
pleted.
Our results show a significant reduction in anxiety and
depression 8 weeks after APT had been commenced. Out-
come was measured by patient self-rating scales in order to
obviate bias inherent in clinical assessments by the therapists.
The HAD scale was used to measure anxiety and depression.
We have found, in a study of 568 patients with cancer, that
factor analysis produced two distinct though correlated fac-
tors corresponding to the questionnaire's anxiety and depres-
sion subscales (Moorey et al., 1991). These results confirm
that the separate subscales of the HAD scale should be used.
We believe that these studies provide a firm basis for the use
of the HAD scale as a measure of anxiety and depression in
patients suffering from cancer. In the present series of emo-
tionally distressed patients, 86% were correctly identified by
high anxiety or depression scores; the remaining 14% (six
patients) scored in the normal range on both subscales.
Statistically significant improvement in anxiety and depres-
sion was observed 8 weeks after commencement of APT
when patients had received an average of five sessions. At the
8 weeks assessment, nearly half the patients were deemed to
have completed therapy. The observed reductions in anxiety
and depression were not merely statistically significant
changes in mean scores but represented clinically significant
improvement. The proportion of patients with high anxiety
scores fell from 84% (n = 37) before therapy to 48% (n = 21)
at final assessment. Depression was less common in our
patients, but the same trend was observed: the proportion of
patients with high depression scores dropped from 50%
(n = 22) before therapy to 25% (n = 11). It should be noted
that no patient became worse as a result of therapy.
Mental adjustment to cancer, measured by the MAC scale,
also improved. At 8 weeks assessment, significant decreases260 S. GREER et al.
in helplessness and anxious preoccupation and a significant
increase in fighting spirit were demonstrated. These changes
have a beneficial effect on quality of life. Active coping
strategies, as subsumed under the heading of fighting spirit,
have been shown to be the most effective in managing the
stress of breast cancer (Rowland & Holland, 1989). Con-
versely, helplessness and anxious preoccupation are cor-
related with depression and anxiety (Watson et al., 1988).
We found no significant predictors of psychological out-
come except, as might be expected, pre-therapy anxiety and
depression scores; high pre-therapy scores were correlated
with high scores at 8 weeks. It is worthy of note that neither
disease stage nor performance status predicted psychological
outcome suggesting that patients with metastatic as well as
local and locoregional disease can benefit from APT. It
should be noted, however, that the present patient sample did
not include any severely disabled patients, i.e. those with
WHO performance status 3 and 4.
The present study has established the feasibility of APT in
a cancer hospital and demonstrated significant improvement
in anxiety, depression and mental adjustment to cancer fol-
lowing a brief course (averaging five sessions) of APT. This
phase I/II study cannot, of course, determine whether APT
was responsible for the observed improvement in quality of
life. But our results are sufficiently encouraging to mount a
controlled trial of APT.
We are grateful to the Cancer Research Campaign for its generous
funding, to Ian Fryatt for valuable statistical advice, to Gill Chesney
our secretary and data manager, and especially to our patients who
worked so hard to get better.
References
BECK, A.T. (1976). Cognitive Therapy and the Emotional Disorders.
International Universities Press: New York.
CAWLEY, R.H. (1983). The principles of treatment and therapeutic
evaluation. In Handbook of Psychiatry 1: General Psychopatho-
logy, Shepherd, M. & Zangwill, 0. (eds), p. 221. Cambridge
University Press: Cambridge.
DEROGATIS, L.R., MORROW, G.R., FETTING, J. & 5 others (1983).
The prevalence of psychiatric disorders among cancer patients.
JAMA, 249, 751.
FOBAIR, P., HOPPE, R.T., BLOOM, J., COX, R., VARGHESE, A. &
SPIEGEL, D. (1986). Psychosocial problems among survivors of
Hodgkin's disease. J. Clin. Oncol., 4, 805.
GREER, S. & WATSON, M. (1987). Mental adjustment to cancer: its
measurement and prognostic importance. Cancer Surv., 6, 439.
GREER, S. (1989). Can psychological therapy improve the quality of
life of patients with cancer? Br. J. Cancer, 59, 149.
HUGHES, J.E. (1987). Psychological and social consequences of
cancer. Cancer Surv., 6, 455.
MAGUIRE, G.P., LEE, E.G., BEVINGTON, D.J., KUCHEMAN, C.S.,
CRABTREE, R.J. & CORNELL, C.F. (1978). Psychiatric problems in
the first year after mastectomy. Br. Med. J., i, 963.
MOOREY, S. & GREER, S. (1989). Psychological Therapy for Patients
with Cancer: a New Approach. Heinemann Medical Books:
Oxford.
MOOREY, S., GREER, S., WATSON, M. & 5 others (1991). The factor
structure and factor stability of the Hospital Anxiety and Depres-
sion scale in patients with cancer. Br. J. Psychiatr. (in the press).
MORRIS, T., GREER, H.S. & WHITE, P. (1977). Psychological and
social adjustment to mastectomy: a two-year follow-up study.
Cancer, 40, 2381.
PLUMB, M. & HOLLAND, J.C. (1977). Comparative studies on
psychological functions in patients with advanced cancer: I. Self-
reported depressive symptoms. Psychosom. Med., 39, 264.
ROWLAND, J.H. & HOLLAND, J.C. (1989). Breast cancer. In Hand-
book ofPsychooncology, Holland, J. & Rowland, J. (eds), p. 193.
Oxford University Press: Oxford.
WATSON, M., GREER, S., YOUNG, J., INAYAT, Q., BURGESS, C. &
ROBERTSON, B. (1988). Development of a questionnaire measure
of adjustment to cancer: the MAC scale. Psychol. Med., 18, 203.
WORLD HEALTH ORGANIZATION (1979). WHO Handbook for
Reporting Results of Cancer Treatment. WHO: Geneva.
ZIGMOND, A.S. & SNAITH, R.P. (1983). The Hospital Anxiety and
Depression scale. Acta Psychiat. Scand., 67, 361.